Authors


Sakshi Sharma, MS

Latest:

Care Management Improves Total Cost of Care for Patients With Dementia

Compared with usual care, a dementia care management program improved various cost of care and utilization metrics in a Medicare managed care population at 12 months.


Xu Ji, PhD

Latest:

Racial and Ethnic Disparities in Telemental Health Use Among Publicly Insured Children

Among publicly insured children with mental health–related encounters, racial and ethnic disparities in telemental health use widened following the onset of the COVID-19 pandemic.


Adekunle Oke, MD, DrPH

Latest:

COVID-19 Vaccine Hesitancy and Health Literacy in US Southern States

COVID-19 vaccine hesitancy is not associated with health literacy. Personal perception of threat was associated with reduced vaccine hesitancy.


Mary Shannon, BA

Latest:

Predictors of and Barriers to Receipt of Advance Premium Tax Credits

Few eligible individuals apply for the Advance Premium Tax Credit due to knowledge barriers. Additionally, specific sociodemographic characteristics appear to predict applying status.


Caitlin Crabb, PhD

Latest:

Reply to “Industry-Informed Perspectives on the Benefits of Rideshare-Based Medical Transportation”

The authors of “Rideshare Transportation to Health Care: Evidence From a Medicaid Implementation” respond to a letter to the editor.


Thomas Leist, MD

Latest:

Future of MS Management

Key opinion leaders in MS provide closing thoughts on the future of MS treatment including digital therapeutics, new generics, and pipeline drugs on the horizon.


Kevin U. Stephens, Sr, JD, MD

Latest:

Defining Value Among Treatment Options

Payer decision-makers discuss defining value among agents for unintended pregnancy, uterine fibroids, and endometriosis.


Clara E. Filice, MD, MPH, MHS

Latest:

Experience Incentivizing Reduction of Racial and Ethnic Disparities in a Medicaid Hospital Quality Incentive Program

Construction of a composite measure, use of a summary disparity statistic, and measure selection are key considerations in the design of equity-focused payment programs.


Rebecca Thorsness, PhD

Latest:

Comparison of Mortality Between Medicare Advantage and Traditional Medicare Beneficiaries With Kidney Failure

The risk-adjusted 1-year mortality rate was not different between Medicare Advantage and traditional Medicare beneficiaries with kidney failure who initiated dialysis.


Mona Chitre, PharmD

Latest:

The Promising Future of Alzheimer Disease Treatment

Panelists conclude the discussion with personal insight into the promising future of Alzheimer disease treatment.


John V. Cox, DO, MBA

Latest:

How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care

Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.


Ishani Ganguli, MD, MPH

Latest:

Stopping the Flood: Reducing Harmful Cascades of Care

Reducing cascades while maintaining our commitment to high-quality care requires equipping patients and clinicians with the information, tools, and support to embrace uncertainty.


Peter Bearse, PhD

Latest:

An Evaluation of a Care Coaching and Provider Referral Intervention for Behavioral Health Needs

Care coaching and behavioral health provider referral programs produce long-term savings, reductions in avoidable utilization, and increases in targeted services to treat behavioral health conditions.


Valerie Reese, MEd

Latest:

Eliminating Defects in Value: Turnaround of an MSSP ACO

A health system transformational leadership framework and management system made visible and eliminated defects in value and was associated with reduced annual Medicare expenditures and increased quality between 2017 and 2020.


Smita Rawal, PhD

Latest:

Innovation, Affordability, Access: Alzheimer Disease Drugs and the Inflation Reduction Act

The authors explore the economic impact and accessibility challenges of new Alzheimer disease drugs under the Inflation Reduction Act, with emphasis on Medicare, pricing, and health care equity.


Mary Acri, PhD

Latest:

Predictors of and Barriers to Receipt of Advance Premium Tax Credits

Few eligible individuals apply for the Advance Premium Tax Credit due to knowledge barriers. Additionally, specific sociodemographic characteristics appear to predict applying status.


Kevin Kennedy, BS

Latest:

Association Between Hospital-Insurer Contract Structure and Hospital Performance

Hospital performance measures, such as prices and costs, are associated with hospital-insurer contract types.


Scott C. Howell, DO

Latest:

Population-Based Return on Investment of Deploying Transient Elastography

Deploying vibration-controlled transient elastography/controlled attenuation parameter devices at the population level is a financially advantageous solution to address the epidemic of fatty liver disease.


Soeren Mattke, MD, ScD

Latest:

Association of Wound Healing With Quality and Continuity of Care and Sociodemographic Characteristics

Based on the analysis of electronic health records from 480 clinics, we found that better care quality and continuity are associated with better-than-expected wound healing performance.


Nathaniel Smith, PhD

Latest:

Real-World Value of Direct-Acting Antivirals for Hepatitis C at Kaiser Permanente Southern California

This analysis demonstrates value and innovation of direct-acting antivirals for the treatment of chronic hepatitis C in the US Kaiser Permanente health system.


N. Benjamin Fredrick, MD.
N. Benjamin Fredrick, MD

Latest:

Health Equity Decision-making: A Q&A With Dr N. Benjamin Fredrick

N. Benjamin Fredrick, MD, of Penn State Hershey Medical Center and Penn State University College of Medicine, speaks on the key themes he presented during his session at the 2023 Health Equity Summit in San Diego, California, as well as topics related to the measurement, creation, and implementation of health equity initiatives.


Waldemar Ríos, MD

Latest:

Contributor: Engaging With Dual-Eligible Members During a Pandemic

When a crisis hits and members become isolated, how can a health plan continue to play an active role in maintaining their health?


Jeromie M. Ballreich, PhD, MS

Latest:

Evaluating Alternatives to QALYs

A better summary measure would be useful, but it is unclear whether there will ever be sufficiently little variation in valuation to design methods in a way that does not require repeated and costly reevaluation of assumptions.


Michael Gao, MD

Latest:

​​Physician-Led Tech Firms Use AI to Counter Drug Denials and Augment Appeals

As drug denials increase, experts discuss the importance of optimizing data to keep up with these changes and implementing artificial intelligence (AI) to reduce the burden on providers and ensure patient access to care and treatment.


Celine Chang Chyi Ng, BPharm

Latest:

Evaluating Smoking Cessation Service at an Emergency Department Clinical Observation Unit

This study aimed to evaluate the impact of a smoking cessation service in a group of patients admitted to a short-stay unit in the emergency department.


Tori Posa, BA

Latest:

Improving Risk Stratification Using AI and Social Determinants of Health

Prediction models combining claims data with social determinants of health and additional, more-timely data sources using artificial intelligence (AI) can better identify individuals with the highest future medical spending.


Eve M Segal, PharmD, BCOP

Latest:

Immunotherapy in the Frontline Management of Advanced and Metastatic NSCLC

The frontline treatment paradigm for patients with advanced or metastatic non−small cell lung cancer (NSCLC) has changed dramatically in the past decade amid efforts to tackle this leading cause of cancer-related mortality. Immune checkpoint inhibitors (ICIs) targeting the programmed cell death protein 1 (PD-1) receptor and its ligand PD-L1 are an important therapeutic option for patients whose tumors lack genetic alterations that dictate response to molecularly targeted therapies. With a growing number of FDA-approved ICI monotherapy and combination therapy options for first-line therapy, the use of biomarkers such as PD-L1 expression has become increasingly important in guiding therapeutic decision making. Presently, PD-L1 expression remains a key biomarker in this setting, in spite of its limitations. This article will evaluate the current and evolving clinical trends in the use of ICIs in the frontline management of metastatic NSCLC, as well as the challenges associated with PD-L1 expression analysis and biomarker implementation.


Julie E. Kim, MD

Latest:

Facilitators of and Barriers to Medicaid Investment in Electronic Consultation Services

In this qualitative investigation, leaders of Medicaid managed care plans were interviewed to identify facilitators of and barriers to electronic consultation for specialty care delivery.


Jeremy Lorber, MD

Latest:

Cold Agglutinin Disease: Clinical Pearls

Take-aways from a discussion on the management of cold agglutinin disease, with expert insight on navigating the healthcare system to optimize patient care.


Yue Li, PhD

Latest:

Availability of Prices for Shoppable Services on Hospital Internet Sites

Only 60% of hospitals display their cash prices and 5% display their minimum negotiated charges on their public websites; many hospitals are in violation of new federal legislation.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo